Physician profile
Shane B Darrah
NPI 1679557375
$17,981.92
in general payments reported to CMS, 2019-2025
40 companies · $1,157 in 2025
The $1,157 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,721 · 2020: $1,442 · 2021: $1,790 · 2022: $1,406 · 2023: $2,071 · 2024: $1,394 · 2025: $1,157.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,622.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $5,229.19 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,505.08 | 2019-2023 | Jardiance |
| Janssen Pharmaceuticals, INC | $1,520.55 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $1,275.29 | 2019-2025 | Watchman Flx, General - Therapies, Watchman |
| Actelion Pharmaceuticals US, INC. | $1,217.39 | 2019-2025 | Uptravi, Opsumit, Opsynvi |
| Novartis Pharmaceuticals Corporation | $1,053.98 | 2019-2025 | |
| Abiomed | $850.37 | 2020-2025 | Impella |
| Abbott Laboratories | $607.46 | 2019-2025 | Amplatzer Amulet, Aveir, Mitraclip |
| Pfizer INC. | $489.75 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $448.36 | 2019-2024 | Farxiga, Andexxa |
| Novo Nordisk INC | $381.52 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| E.R. Squibb & Sons, L.L.C. | $339.08 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $201.91 | 2021-2023 | Nexletol |
| Sanofi-Aventis U.S. LLC | $182.91 | 2019-2021 | |
| Medtronic, INC. | $173.74 | 2023 | Azure Xt Dr Mri Surescan |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $164.91 | 2023-2024 | Inspire |
| Bracco Diagnostics INC. | $152.66 | 2022-2025 | |
| Atricure, INC. | $125.82 | 2023 | |
| Alnylam Pharmaceuticals INC. | $122.14 | 2020-2025 | Amvuttra, Onpattro |
| Bayer Healthcare Pharmaceuticals INC. | $113.83 | 2022-2023 | |
| Cvrx, INC. | $98.45 | 2025 | Barostim Neo System |
| Teleflex LLC | $88.22 | 2023 | Trapliner |
| Ge Healthcare | $85.77 | 2023 | Giraffe Omnibed Carestation |
| Daiichi Sankyo INC. | $70.01 | 2024-2025 | Injectafer |
| Gilead Sciences, INC. | $63.75 | 2019 | |
| United Therapeutics Corporation | $61.26 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $54.39 | 2022 | |
| Amgen INC. | $51.28 | 2019-2020 | |
| Shockwave Medical, INC | $40.29 | 2020-2021 | |
| Astellas Pharma US INC | $39.10 | 2019 | |
| Irhythm Technologies, INC. | $32.35 | 2020-2023 | Zio Xt Patch |
| Siemens Medical Solutions USA, INC. | $24.73 | 2025 | Artis Icono Biplane |
| Innovation Technologies INC | $22.18 | 2024 | Irrisept |
| Biotronik INC. | $20.38 | 2025 | Pantera Leo, Orsiro Mission |
| Lundbeck LLC | $19.53 | 2019 | |
| Merck Sharp & Dohme LLC | $15.58 | 2025 | Verquvo |
| Osprey Medical INC | $13.00 | 2019 | |
| Amarin Pharma, INC. | $12.50 | 2022 | |
| Vivaquant INC, Dba Rhythm Express | $6.79 | 2025 | Rhythm Express |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $6.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Darrah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.